HealthManagement, Volume 16 - Issue 3, 2016

Another Big First For Hologic

2D/3D Imaging on a Dedicated Prone Breast Biopsy System


Breast tomosynthesis imaging, Hologic calls it 3D mammography™, is ‏proving to be the best modality for breast cancer imaging. The Hologic ‏tomosynthesis system has demonstrated superior clinical performance ‏to conventional 2D mammography in a number of metrics, in particular ‏showing improved detection of invasive cancers and reductions in ‏recall rate. Now Hologic is offering their tomosynthesis technology on ‏a dedicated prone breast biopsy system.


The new CE-marked Affirm™ prone biopsy system provides enhanced ‏2D/3D biopsy imaging and faster, easier access to the breast. The new ‏product is an important step forward in biopsy technology — allowing ‏doctors to better target lesions found with 3D mammography™ exams, ‏as well as other screening modalities — with exceptional imaging, ‏improved workflow and seamless, 360-degree access to the breast. ‏


Clinicians prefer prone systems for breast biopsies


Thousands of clinicians worldwide prefer prone patient positioning ‏instead of upright systems for breast biopsies as prone systems support ‏the patient stably throughout the procedure while isolating them from ‏the biopsy needle. This provides a better overall patient experience. ‏Alejandro Tejerina, M.D., a radiologist with the Centro de Patologia de ‏la Mama, Tejerina Foundation, in Madrid, Spain, one of the first adopters ‏of the new Affirm™ prone system, reports that the feedback from the ‏first wave of patients is very positive.


“We have been suffering to handle complex biopsies of subtle lesions ‏like faint calcifications or distortions that we were only able to see ‏on 3D images,” Dr. Tejerina says. “Older breast biopsy systems are ‏restricted to 2D imaging with a narrow window for targeting the lesions. ‏Often they required multiple x-ray exposures to find and position the ‏suspect tumor for the biopsy needle. With tomosynthesis imaging on ‏the new Affirm™ prone system, there is a much wider field of view, the ‏biopsy device can be positioned anywhere in a 360-degree circle, and ‏areas of suspicion seen only with 3D imaging can be easily biopsied.” ‏On the previous Hologic biopsy table the biopsy device had to be ‏positioned manually, "the new system does this for us automatically, ‏which saves time,” Dr. Tejerina says. “The software really streamlines ‏our workflow, so the procedure goes faster.” The new Affirm™ Prone ‏table uses translucent paddles and a wider detector. “This helps us ‏see lesions in the first scout and significantly reduce the number of ‏images needed to get to the lesion.”


Helping the Centre Lead in Breast Health


The Centro de Patologia de la Mama, Tejerina Foundation has been ‏leading the way in women’s breast health for over 40 years. In 2000, ‏the Centre pioneered the use of digital mammography in Spain. The ‏Centre was first center in Spain to install a stereotactic guided prone ‏biopsy table in 1997. In 2010 the Centre installed a Hologic Selenia® ‏Dimensions® breast tomosynthesis system, the first site in Spain to use ‏the innovative technology. In 2010 the Centre was also the first site ‏in Spain to combine the Hologic Affirm™ upright biopsy system with ‏the Hologic tomosynthesis system. In 2015 the Centre began offering ‏Hologic’s I-View™ contrast enhanced 2D imaging along with a 3D scan, ‏further increasing the value of a contrast mammography procedure. ‏


The new Hologic Affirm™ prone biopsy system significantly expands ‏the Centre’s breast biopsy portfolio and keeps the Centre in the lead ‏in offering the latest in breast health services to the women of Spain.

Related Articles

The value and importance of multidisciplinary teams in breast cancer was demonstrated at the European Society of Breast Imaging (EUSOBI)... Read more

E x p a n d i ng L e a d e r s h i p b a s e d o n c l i n i c a l e... Read more

M o r e c o m f o r t a n d i n c r e a s e d c o n f i d e n c e f r o m... Read more

Alejandro Tejerina, Tejerina Foundation, tomosynthesis, Affirm prone biospy, breast imaging, breast cancer, 3D mammography Another Big First For Hologic

No comment

Please login to leave a comment...